Online auctions

News
Article

Pharmaceutical Technology Europe

Pharmaceutical Technology EuropePharmaceutical Technology Europe-03-01-2006
Volume 18
Issue 3

So could the online auction formula be extended to the pharmaceutical industry? It might be a great way to make some big savings.

Online shopping has become something of a phenomenon during the past decade. Why bother trawling through shops when you can order just about anything online — you don't even have to leave the comfort of your own seat, let alone the house. A few clicks and it's completed. OK, so your purchase may take a couple of days longer to arrive compared with going to a shop, but the savings far outweigh the delay. And besides, it's always nicer and much more exciting to get parcels through the post.

Gurminder Marwaha

I am happy to admit that I do most of my shopping online — a favourite is grocery shopping. Not that it gives me any pleasure; far from it. But, it's a lot easier than going to a supermarket full of screaming kids, unhelpful staff and coming out with 'beep beep beep' from the tills ringing in your ears. It takes less than 30 minutes to do a weekly shop online and they deliver right to my door. Perfect.

One of the best things to happen to online shopping has been web-based auction sites. There's something for everyone on these, and if you're quick enough you can grab an absolute bargain. But they have become more than just online auction houses; they are now proper market places, fully fledged institutions.

So could the online auction formula be extended to the pharmaceutical industry? For me, the customer should always come first and this would be a great way to make some big savings. Vendors needn't worry either — the auction process would help the best vendors make some good money. Something for everyone then!

Of course, the reality is that this would never happen. The market may witness cheap imitations and rip off merchants — though judging by some comments that I have heard recently, this is happening to a degree anyway. I guess the regulatory authorities wouldn't be too pleased either.

It's a shame really, because it would be quite exciting to watch pharmaceutical companies from across the globe battling it out to find the cheapest raw materials and process equipment. The serious point is that it would certainly bring our heavily fragmented industry much closer together — it would also be a lot more fun, and that never hurts anybody.

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content